Literature DB >> 29517956

Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.

Kenneth Anderson1, Nofisat Ismaila1, Robert A Kyle1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29517956     DOI： 10.1200/JOP.17.00013

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  2 in total

1.  Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations.

Authors:  J E Brown; S L Wood; C Confavreux; M Abe; K Weilbaecher; P Hadji; R W Johnson; J A Rhoades; C M Edwards; P I Croucher; P Juarez; S El Badri; G Ariaspinilla; S D'Oronzo; T A Guise; C Van Poznak
Journal:  J Bone Oncol       Date:  2021-06-11       Impact factor: 4.072

Review 2.  Evidence-based supportive care in multiple myeloma.

Authors:  Anum Qureshi; Muhammad Junaid Tariq; Zunairah Shah; Muhammad Abu Zar; Shehroz Aslam; Abdul Rafae; Madeeha Shafqat; Mustafa Nadeem Malik; Muhammad Salam Faisal; Faiz Anwer
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-08-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.